- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.09. | PRESSURE BIOSCIENCES INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 19.08. | PRESSURE BIOSCIENCES INC - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 17.07. | PRESSURE BIOSCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
| PRESSURE BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 03.07. | PRESSURE BIOSCIENCES INC - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Pressure BioSciences, Inc.: Pressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray | 1 | GlobeNewswire (USA) | ||
| 18.06. | Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET | 1 | GlobeNewswire (USA) | ||
| 13.06. | Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET | 1 | GlobeNewswire (USA) | ||
| 07.06. | PRESSURE BIOSCIENCES INC - 10-K, Annual Report | 2 | SEC Filings | ||
| 15.02. | Pressure BioSciences, Inc.: Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing | 438 | GlobeNewswire (Europe) | CANTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a leading innovator in high-pressure nanotechnology and a pioneer in the development... ► Artikel lesen | |
| 05.02. | Pressure BioSciences, Inc.: Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness | 248 | GlobeNewswire (Europe) | Multi-Patented Nanoemulsification Platform Enables Wide-Range of Best-in-Class Health and Wellness Products - Revenue Impact of $5 Million in 2024 Anticipated with Further Acceleration in 2025 & Beyond... ► Artikel lesen | |
| 18.01. | Pressure BioSciences, Inc.: Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order | 203 | GlobeNewswire (Europe) | SOUTH EASTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based... ► Artikel lesen | |
| 04.01. | Pressure BioSciences Inc.: Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational Technologies | 314 | ACCESSWIRE | Artificial Intelligence/Machine Learning Also Expected to Significantly Accelerate Advancements in PBIO's Patented, Innovative, and Enabling UltraShear Processing PlatformSOUTH EASTON, MA / ACCESSWIRE... ► Artikel lesen | |
| 21.12.23 | Pressure BioSciences Inc.: Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform | 240 | ACCESSWIRE | Beyond Formidable Enhancements for the Food and Beverage Industry, UST Offers Promising Applications in Drug Delivery, Cosmetics, Biotechnology, Agriculture, and Advanced NanomaterialsSOUTH EASTON,... ► Artikel lesen | |
| 12.12.23 | Pressure BioSciences Inc.: Pressure BioSciences' UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores | 378 | ACCESSWIRE | Novel Results Published in Respected Peer-Reviewed Food Science and Emerging Technologies Journal - Discussions Underway with Beverage Industry CompaniesSOUTH EASTON, MA / ACCESSWIRE / December 12,... ► Artikel lesen | |
| 01.12.23 | Pressure BioSciences Inc.: Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador | 408 | ACCESSWIRE | Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of the Agreement. "Valor CBD" Topical Spray Now Available on the VST Website.SOUTH EASTON, MA /... ► Artikel lesen | |
| 21.11.23 | Pressure BioSciences Inc.: Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023 | 345 | ACCESSWIRE | Investor Call Scheduled for Tuesday, November 21, 2023 at 4:30 p.m. ETSOUTH EASTON, MA / ACCESSWIRE / November 21, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in... ► Artikel lesen | |
| 20.11.23 | Pressure BioSciences Inc.: Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update | 324 | ACCESSWIRE | Conference Call Scheduled for Tuesday, November 21 at 4:30pm ETSOUTH EASTON, MA / ACCESSWIRE / November 20, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MOUNTAIN VALLEY MD | 0,014 | -23,40 % | Mountain Valley MD Holdings Inc: Mountain Valley MD talks Quicksome manufacturing work | ||
| CYTOSORBENTS | 0,829 | 0,00 % | CytoSorbents; Converge Biotech: CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India | PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 152,70 | +0,20 % | Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now? | ||
| CENTENE | 54,36 | -0,40 % | Chutes & Ladders-Centene president to retire, Abridge and AccessHope tap industry execs | ||
| FRESENIUS | 33,360 | +1,80 % | Fresenius-Aktie: "Top Pick" | Nach der Vorlage der Zahlen zum abgelaufenen dritten Quartal haben zahlreiche Analysten das Papier des Gesundheitskonzerns Fresenius erneut genauer analysiert. Während sich Goldman Sachs zu keiner Kaufempfehlung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 50,18 | 0,00 % | DZ BANK stuft Siemens Healthineers auf 'Neutral' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat das Kursziel für Siemens Healthineers nach Zahlen zum vierten Geschäftsquartal von 52 auf 54 Euro angehoben und die Einstufung auf "Halten" belassen. Diese... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,770 | +2,05 % | Aktienmarkt: Fresenius Medical Care-Aktie tritt auf der Stelle (39,71 €) | Die Wertschätzung für das Wertpapier von Fresenius Medical Care hat sich an der Börse heute kaum geändert. Zuletzt zahlten Investoren für die Aktie 39,71 Euro. Kaum verändert im Vergleich zu der letzten... ► Artikel lesen | |
| GERRESHEIMER | 73,00 | -2,93 % | Evotec, Gerresheimer, K+S, PNE, Redcare Pharmacy, SMA Solar u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 58,50 | -0,43 % | Carl Zeiss Meditec Aktie: Fakten ohne großen Wandel | Die Carl Zeiss Meditec Aktie erlebte am Freitag einen erfreulichen Handelstag an der Frankfurter Börse. Im XETRA-Handel verzeichnete das Wertpapier einen beachtlichen Zuwachs von 2,2 Prozent und erreichte... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 19,630 | +2,29 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 11,490 | -10,23 % | Alignment Healthcare announces offering of $330M convertible debt | ||
| HIMS & HERS HEALTH | 18,350 | -0,11 % | Starke Konkurrenz befürchtet: Hims & Hers: Katastrophaler Crash nach Allzeithoch! | © Foto: UnsplashDie Anteile der Online-Apotheke Hims & Hers stehen unter Druck, nachdem E-Commerce-Riese Amazon angekündigt hat, einen Telemedizin-Service zu starten.Hinter der Aktie der US-Online-Apotheke... ► Artikel lesen | |
| TEMPUS AI | 52,36 | -7,54 % | Short Interest in Tempus AI, Inc. (NASDAQ:TEM) Grows By 19.2% | ||
| PROCEPT BIOROBOTICS | 88,89 | +3,46 % | PROCEPT started with Hold at Jefferies on valuation | ||
| ECKERT & ZIEGLER | 38,480 | -4,33 % | EQS-Adhoc: Eckert & Ziegler SE: Eckert & Ziegler und Telix Pharmaceuticals schließen Kooperations- und Lizenzvertrag für Actinium-225 | EQS-Ad-hoc: Eckert & Ziegler SE / Schlagwort(e): Kooperation
Eckert & Ziegler und Telix Pharmaceuticals schließen Kooperations- und Lizenzvertrag für Actinium-225
13.11.2024 / 08:54 CET/CEST
Veröffentlichung... ► Artikel lesen |
PRESSURE BIOSCIENCES INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRESSURE BIOSCIENCES INC finden Sie auf Wallstreet Online.
